by Matthew Johnson | Dec 24, 2018 | Pharmaceutical, PTAB News
Sen. Orrin Hatch has introduced a bill that would augment the Hatch-Waxman Act, limiting challengers ability to proceed with patent challenges both in court and at the PTAB. Following is the introduction of the “Hatch-Waxman Integrity Act of 2018.” The...
by Matthew Johnson | Dec 20, 2018 | PTAB News
The 2019 PTAB Bar Association Annual Conference will take place March 14 – 15, 2019, at the Ritz-Carlton in Washington, D.C. Pre-conference sessions will be offered March 13. The conference will bring together practitioners, in-house counsel, and members of the bench...
by Matthew Johnson | Dec 18, 2018 | Evidentiary Issues
By Jihong Lou, Levent Herguner, Alex Li, and Matt Johnson – On December 6, 2018, the PTAB hosted a Boardside Chat webinar on hearsay and authentication. The Administrative Patent Judges presenting the webinar were Michael Zecher, Tom Giannetti, and Grace...
by Matthew Johnson | Dec 17, 2018 | Prior Art Issues
By Matt Johnson – The PTAB’s October statistics indicate a quiet first month of FY 2019, with 115 petitions for IPR, 5 PGR petitions, and 2 CBM petitions being filed in October. That filing rate would extrapolate to 1464 total filings for the year,...
by Matthew Johnson | Dec 13, 2018 | Amendment Practice
By Levent Herguner and Matt Johnson – On November 26, 2018, the PTAB entered its Final Written Decision in Intel Corp. v. Alacritech, Inc., Case IPR2017-01391, denying Patent Owner Alacritech, Inc.’s Motion to Amend in the inter partes review of certain claims...
